
BroadCancerIDWall
2.9K posts

BroadCancerIDWall
@BroadCancer
The retweets do not represent the Broad Cancer Program. This account serves to push content to an internal web display.
Katılım Temmuz 2018
123 Takip Edilen149 Takipçiler
BroadCancerIDWall retweetledi

At @DanaFarber, we envision a world free from the fear and burden of cancer. We are very proud to advance our collaboration with Oncoclínicas to help improve cancer care in Brazil. dana-farber.org/newsroom/news-…
English
BroadCancerIDWall retweetledi
BroadCancerIDWall retweetledi

The 23Q2 data release is live on depmap.org! We are excited to share new CRISPR and omics data, an update in our CRISPR method, Chronos, a new Target Discovery app and a new cell line page. #DepMapPortal #DepMap #OpenScience #CancerResearch

English
BroadCancerIDWall retweetledi
BroadCancerIDWall retweetledi

We are thrilled that patients with metastatic HR+, HER2- breast cancer now have a promising treatment option following the FDA's approval a novel antibody drug-conjugate therapy based on a study led by @stolaney1. dana-farber.org/newsroom/news-…

English
BroadCancerIDWall retweetledi
BroadCancerIDWall retweetledi

So excited to share our work on the genetic architecture of rare coding variation, now published in @Nature
nature.com/articles/s4158…
This work was led by superstar co-first authors @danweiner92 and @NadigAjay
English
BroadCancerIDWall retweetledi
BroadCancerIDWall retweetledi

Applications are now open for the 2023 Angelika Amon Young Scientist Awards.
The prize is awarded to grad students studying life sciences or biomedical research outside the U.S. who embody Dr. Amon’s infectious enthusiasm for discovery science.
ki.mit.edu/events/prizes-…

English
BroadCancerIDWall retweetledi
BroadCancerIDWall retweetledi

A new generation of cancer-preventing vaccines could wipe out tumors before they form.
Learn more on #WorldCancerDay: scim.ag/1ps @ScienceVisuals

English
BroadCancerIDWall retweetledi

Really nice spotlight article about our work on TBK1 as an immunotherapy target in @TrendsImmuno by @FitzgeraldKate and @MichelleKellih3 . Thanks for writing up this nice summary! Original article here: nature.com/articles/s4158…
Trends in Immunology@TrendsImmuno
TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy dlvr.it/ShxsNF #immunology
English

Congratulations to Kathleen Mulvaney!
Kathleen Mulvaney@KathleenMulvan4
The Mulvaney Lab will launch this Fall in DC! I’m excited to start my tenure-track position at Fralin Biomedical Research Institute, Virginia Tech Carilion School of Medicine with dual membership at the Cancer & Immunology Research Center of Children’s National Hospital.
English
BroadCancerIDWall retweetledi
BroadCancerIDWall retweetledi

CAR T in solid tumors: A 31-year-old with sDMG has experienced a near-complete (>95%) reduction in tumor volume and a 17-year-old with DIPG experienced a near-complete (>98%) reduction in volume of a pontine tumor. aacrjournals.org/cancerres/arti…
English
BroadCancerIDWall retweetledi

We asked what would happen if we flipped a research paradigm and partnered with prostate cancer patients to bring genomics research to them
At their doorsteps
Wherever they live...
@jettcrowdis @DanaFarber @broadinstitute @EmCollective @CellGenomics [1/n] cell.com/cell-genomics/…
English
BroadCancerIDWall retweetledi

We’re very proud that President Biden has chosen Dr. Monica Bertagnolli to lead the NCI. She is an eminent surgeon with extensive clinical and leadership experience. Monica will be a superb leader at the NCI at a time when cancer research is so promising. dana-farber.org/newsroom/news-…
English
BroadCancerIDWall retweetledi








